ArticleGlobal health & medicine2020

Nucleos(t)ide reverse transcriptase inhibitor-sparing regimens in the era of standard 3-drug combination therapies for HIV-1 infection.

Keita Uchitsubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.